2060 Foundation is opening its first fundraising round to accelerate research, create its first prototype, develop its intellectual property, and move toward an initial commercial product.
Public source
Publisher name
Public post
The future of longevity is being grown in the lab. What if we could recreate one of the most regenerative biological environments in human life and turn it into a platfo…
Company
2060 Foundation
The purpose of the "2060 Foundation" is to help Humanity Defeat Aging by 2060
- Industry
- Health and Human Services
- Company size
- 2–10 employees
About 2060 Foundation
The purpose of the "2060 Foundation" is to help Humanity Defeat Aging by 2060
See moreLatest activity
Latest activity from 2060 Foundation
6 signals
Research & Knowledge
2060 Foundation reports encouraging preclinical results across three species including dogs affected by naturally occurring Alzheimer like dementia.
Capital & Finance
2060 Foundation secured backing from investors including some of the biggest pharma companies worldwide and is raising an additional seven million US dollars to complete its first in human Alzheimer trial.
Products & Services
2060 Foundation has already signed letters of intent with biotechnology companies and researchers working in longevity and regenerative biology.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Longevity Science Foundation
Longevity Science Foundation is raising $250,000 to fund critical early-stage research in women’s health through Invested in Her.
Capital & Finance
LongGame Ventures
LongGame Ventures is a fund focused on early-stage investments in longevity and biotech.
Capital & Finance
AgeTechX
AgeTechX selected 20 shortlisted companies for the Ones to Watch panel in Berlin on 6 October.
Capital & Finance
Sarcomatrix
Sarcomatrix Therapeutics is raising capital under Regulation D Rule 506(c) for its early-stage therapeutic candidate programs.
Capital & Finance
Korion Health